Home / Compliance actions / 669353

FDA Warning Letter — Abbott Laboratories

Case 669353 — FEI 1513768

The FDA took a Warning Letter action against Abbott Laboratories on Oct 24, 2023 (Columbus, OH). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Abbott Laboratories
Date
Oct 24, 2023
Fiscal Year
2024
Product Type
Biologics
Center
CBER
Location
Columbus, OH (United States)

Facility

Recent inspections

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.